Nippon Air conditioning Services Co., Ltd. (TYO:4658)

Verve Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	10,644	8,996	6,989	6,582	7,253	6,686
Cash & Short-Term Investments	10,644	8,996	6,989	6,582	7,253	6,686
Cash Growth	23.96%	28.72%	6.18%	-9.25%	8.48%	11.06%
Accounts Receivable	11,056	16,770	16,037	14,223	11,618	12,295
Other Receivables	1,194	182	510	221	471	340
Receivables	12,250	16,952	16,547	14,444	12,089	12,635
Inventory	1,401	622	703	726	656	489
Other Current Assets	611	2,092	2,148	1,693	1,655	346
Total Current Assets	24,906	28,662	26,387	23,445	21,653	20,156
Property, Plant & Equipment	13,061	12,929	9,819	8,448	8,238	8,284
Long-Term Investments	6,774	6,447	6,205	5,096	4,642	5,831
Other Intangible Assets	80	73	62	74	76	153
Long-Term Deferred Tax Assets	-	454	474	496	529	480
Other Long-Term Assets	817	3	2	2	2	2
Total Assets	45,638	48,568	42,949	37,561	35,140	34,906
Accounts Payable	3,570	9,138	7,886	7,500	6,319	5,944
Accrued Expenses	3,022	3,251	2,534	2,029	1,806	1,976
Short-Term Debt	550	550	870	640	320	470
Current Portion of Long-Term Debt	687	699	259	157	176	185
Current Income Taxes Payable	475	1,695	1,219	740	1,332	781
Current Unearned Revenue	-	-	-	-	-	98
Other Current Liabilities	5,164	1,363	1,724	1,171	995	906
Total Current Liabilities	13,468	16,696	14,492	12,237	10,948	10,360
Long-Term Debt	2,362	2,356	578	200	357	534
Long-Term Deferred Tax Liabilities	-	96	264	115	2	398
Other Long-Term Liabilities	397	107	91	81	89	76
Total Liabilities	19,435	22,446	18,739	15,858	14,660	14,524
Common Stock	1,139	1,139	1,139	1,139	1,139	1,139
Additional Paid-In Capital	1,164	1,164	1,163	1,159	1,168	1,174
Retained Earnings	20,426	20,761	19,176	17,459	16,482	15,178
Treasury Stock	-742	-742	-875	-931	-807	-359
Comprehensive Income & Other	4,025	3,602	3,430	2,715	2,353	3,132
Total Common Equity	26,012	25,924	24,033	21,541	20,335	20,264
Minority Interest	191	198	177	162	145	118
Shareholders' Equity	26,203	26,122	24,210	21,703	20,480	20,382
Total Liabilities & Equity	45,638	48,568	42,949	37,561	35,140	34,906
Total Debt	3,599	3,605	1,707	997	853	1,189
Net Cash (Debt)	7,045	5,391	5,282	5,585	6,400	5,497
Net Cash Growth	-3.03%	2.06%	-5.42%	-12.73%	16.43%	27.25%
Net Cash Per Share	202.22	154.83	151.90	160.72	181.58	153.41
Filing Date Shares Outstanding	34.58	34.58	34.36	34.28	34.24	34.78
Total Common Shares Outstanding	34.58	34.58	34.36	34.27	34.41	34.96
Working Capital	11,438	11,966	11,895	11,208	10,705	9,796
Book Value Per Share	752.29	749.74	699.40	628.48	591.04	579.72
Tangible Book Value	25,932	25,851	23,971	21,467	20,259	20,111
Tangible Book Value Per Share	749.97	747.63	697.59	626.33	588.83	575.34
Order Backlog	-	10,510	8,491	6,268	3,867	3,046

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.